Ernst SM, von der Thusen JH, Dubbink HJ, Dingemans AC, et al. A Response to the Letter to the Editor: Comment on "Clinical Utility of Circulating Tumor DNA in Patients With Advanced KRAS(G12C)-Mutated NSCLC Treated With Sotorasib". J Thorac Oncol 2024;19:e44-e45.
PMID: 39242150